150 related articles for article (PubMed ID: 32989920)
1. Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers.
Begley R; Anderson K; Watkins TR; Weng W; Ampaw L; Qin A; Kearney BP; Mathias A
Clin Pharmacol Drug Dev; 2021 Apr; 10(4):376-383. PubMed ID: 32989920
[TBL] [Abstract][Full Text] [Related]
2. Effect of empagliflozin on the steady-state pharmacokinetics of ethinylestradiol and levonorgestrel in healthy female volunteers.
Macha S; Mattheus M; Pinnetti S; Woerle HJ; Broedl UC
Clin Drug Investig; 2013 May; 33(5):351-7. PubMed ID: 23512637
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers.
Cherala G; Nelson C; Guo Y; Mathur A; Tarnowski T; Othman AA
Clin Transl Sci; 2022 Jun; 15(6):1492-1499. PubMed ID: 35266297
[TBL] [Abstract][Full Text] [Related]
4. Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women.
Sivasubramanian R; Chakraborty A; Rouzade-Dominguez ML; Neelakantham S; Jakab A; Mensinga T; Legangneux E; Woessner R; Ufer M
Int J Clin Pharmacol Ther; 2015 Jul; 53(7):550-6. PubMed ID: 25943176
[TBL] [Abstract][Full Text] [Related]
5. The JAK1 Inhibitor Upadacitinib Has No Effect on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol: A Study in Healthy Female Subjects.
Mohamed MF; Trueman S; Feng T; Friedman A; Othman AA
J Clin Pharmacol; 2019 Apr; 59(4):510-516. PubMed ID: 30500075
[TBL] [Abstract][Full Text] [Related]
6. A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
Ankrom W; Jackson Rudd D; Zhang S; Fillgrove KL; Gravesande KN; Matthews RP; Brimhall D; Stoch SA; Iwamoto MN
J Int AIDS Soc; 2021 Dec; 24(12):e25858. PubMed ID: 34935295
[TBL] [Abstract][Full Text] [Related]
7. Effect of the hepatitis C virus protease inhibitor faldaprevir on the pharmacokinetics of an oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Sabo JP; Lang B; Elgadi M; Huang F
Antimicrob Agents Chemother; 2015 Jan; 59(1):514-9. PubMed ID: 25385099
[TBL] [Abstract][Full Text] [Related]
8. Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.
Friedrich C; Port A; Ring A; Graefe-Mody U; Giessmann T; Iovino M; Woerle HJ
Clin Drug Investig; 2011; 31(9):643-53. PubMed ID: 21714581
[TBL] [Abstract][Full Text] [Related]
9. Influence of avosentan (SPP3OI) on the pharmacokinetics of a second generation oral contraceptive containing ethinylestradiol and levonorgestrel in healthy female volunteers.
Dieterle W; Mann J
Int J Clin Pharmacol Ther; 2006 Dec; 44(12):668-74. PubMed ID: 17190377
[TBL] [Abstract][Full Text] [Related]
10. Effect of letermovir on levonorgestrel and ethinyl estradiol pharmacokinetics
.
Adedoyin A; Cho CR; Fox-Bosetti S; Macha S; Zhao T; Liu F; Panebianco D; O'Reilly TE; McCrea J; Stoch SA; Iwamoto M
Int J Clin Pharmacol Ther; 2019 Sep; 57(9):450-457. PubMed ID: 31232280
[TBL] [Abstract][Full Text] [Related]
11. Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults.
Lin S; Ionescu A; Maynard-Scott J; Kennedy M; Walling DP; Furey M; Singh JB
Clin Transl Sci; 2024 May; 17(5):e13791. PubMed ID: 38700236
[TBL] [Abstract][Full Text] [Related]
12. Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.
Ankrom W; Xu J; Vallee MH; Dockendorf MF; Armas D; Boinpally R; Min KC
J Clin Pharmacol; 2020 Sep; 60(9):1157-1165. PubMed ID: 32297990
[TBL] [Abstract][Full Text] [Related]
13. No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combination.
Heger-Mahn D; Pabst G; Dienel A; Schläfke S; Klipping C
Drugs R D; 2014 Dec; 14(4):265-72. PubMed ID: 25319228
[TBL] [Abstract][Full Text] [Related]
14. Effects of Flibanserin on the Pharmacokinetics of a Combined Ethinylestradiol/Levonorgestrel Oral Contraceptive in Healthy Premenopausal Women: A Randomized Crossover Study.
Johnson-Agbakwu C; Brown L; Yuan J; Kissling R; Greenblatt DJ
Clin Ther; 2018 Jan; 40(1):64-73. PubMed ID: 29198449
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult women.
Trezza C; Ford SL; Gould E; Lou Y; Huang C; Ritter JM; Buchanan AM; Spreen W; Patel P
Br J Clin Pharmacol; 2017 Jul; 83(7):1499-1505. PubMed ID: 28087972
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Oral Combination Contraceptive Drugs Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Chinese Volunteers.
Xin X; Wu Y; Liu X; Sun C; Geng T; Ding L
Drug Res (Stuttg); 2016 Feb; 66(2):100-6. PubMed ID: 26037079
[TBL] [Abstract][Full Text] [Related]
17. Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.
Kothare PA; Seger ME; Northrup J; Mace K; Mitchell MI; Linnebjerg H
BMC Clin Pharmacol; 2012 Mar; 12():8. PubMed ID: 22429273
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Effect of Tofacitinib on the Pharmacokinetics of Oral Contraceptive Steroids in Healthy Female Volunteers.
Menon S; Riese R; Wang R; Alvey CW; Shi H; Petit W; Krishnaswami S
Clin Pharmacol Drug Dev; 2016 Sep; 5(5):336-42. PubMed ID: 27138968
[TBL] [Abstract][Full Text] [Related]
19. The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrel.
Olsson B; Landgren BM
Clin Ther; 2001 Nov; 23(11):1876-88. PubMed ID: 11768839
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens.
Darwish M; Bond M; Ricciotti N; Hsieh J; Fiedler-Kelly J; Grasela T
Reprod Sci; 2014 Nov; 21(11):1401-10. PubMed ID: 24647707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
